Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
40,117,493
-
Shares change
-
+1,159,146
-
Total reported value, excl. options
-
$156,470,492
-
Value change
-
+$2,266,222
-
Put/Call ratio
-
7.28%
-
Number of buys
-
40
-
Number of sells
-
-54
-
Price
-
$3.9
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2022
117 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40,117,493 shares
of 202,731,676 outstanding shares and own 19.79% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (9,455,000 shares), EVENTIDE ASSET MANAGEMENT, LLC (5,372,512 shares), Alpine Global Management, LLC (4,448,017 shares), VANGUARD GROUP INC (3,999,493 shares), BlackRock Inc. (3,631,310 shares), FEDERATED HERMES, INC. (1,882,351 shares), DIMENSIONAL FUND ADVISORS LP (945,480 shares), STATE STREET CORP (892,680 shares), GEODE CAPITAL MANAGEMENT, LLC (794,972 shares), and PLATINUM INVESTMENT MANAGEMENT LTD (777,590 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.